90 studies found for:    Open Studies | "Dermatitis, Atopic"
Show Display Options
Rank Status Study
21 Not yet recruiting Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
Conditions: Atopic Dermatitis;   Eczema
Intervention: Biological: Moisturizer with each subject's own antimicrobial bacteria
22 Recruiting Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: ILV-094;   Drug: Placebo Comparator
23 Recruiting Pharmacokinetic Study of Topical GSK2894512 Cream
Condition: Dermatitis, Atopic
Intervention: Drug: GSK2894512 Topical Cream
24 Recruiting A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: CT327 ointment;   Drug: placebo
25 Recruiting Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema
Condition: Mild to Moderate Atopic Dermatitis
Interventions: Drug: SB011, 2 % (Water/Oil/Water) emulsion of hgd40;   Drug: Multiple W/O/W formulation, active ingredient-free vehicle
26 Recruiting Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
Condition: Atopic Dermatitis
Intervention:
27 Recruiting A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis
Conditions: Asthma;   Atopic Dermatitis;   Healthy
Interventions: Drug: Part 1: CNTO 7160;   Drug: Part 2 (Asthma): CNTO 7160;   Drug: Part 2 (Atopic Dermatitis): CNTO 7160;   Drug: Part 1 and Part 2: Placebo
28 Not yet recruiting Atopic Dermatitis Adherence Study
Condition: Atopic Dermatitis/Eczema
Intervention: Behavioral: electronic reminders
29 Recruiting Cognitive Behavior Therapy for Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Behavioral: Cognitive behavior therapy
30 Recruiting Photocil (Topical) for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Photocil for Atopic Dermatitis;   Other: Placebo - Sunscreen (SPF 2)
31 Recruiting KM110329 in Adult Patients With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Dietary Supplement: KM110329;   Dietary Supplement: Placebo
32 Recruiting Placebo Effect in the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Dimetindene;   Behavioral: instruction;   Other: conditioning
33 Recruiting Oral DS107G in Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: DS107G;   Drug: Placebo
34 Recruiting Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention: Drug: Fluocinonide cream
35 Not yet recruiting Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children
Condition: Atopic Dermatitis
Interventions: Drug: Probiatop;   Drug: Placebo
36 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Condition: Atopic Dermatitis
Intervention:
37 Recruiting Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: CLS001;   Drug: Vehicle
38 Not yet recruiting An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)
Condition: Atopic Dermatitis
Interventions: Drug: LEO 32731 cream;   Drug: LEO 32731 cream vehicle
39 Not yet recruiting Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: MEDI9929;   Biological: Placebo
40 Recruiting A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal
Condition: Dermatitis, Atopic
Intervention: Drug: Triamcinolone 0.1%

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years